Clinical Trials Logo

Hoarding Disorder clinical trials

View clinical trials related to Hoarding Disorder.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04035850 Withdrawn - Hoarding Disorder Clinical Trials

Vortioxetine for the Treatment of Hoarding Disorder

Start date: August 1, 2019
Phase: Phase 3
Study type: Interventional

The present study is a single-group open-label investigation of the potential efficacy of Vortioxetine for treatment of 30 adult volunteers with Hoarding Disorder (HD) (flexible-dose study, with a target dose range 5-25mg). The proposed study will be the first Vortioxetine study in HD, and conducted at the Anxiety Treatment and Research Clinic (ATRC) Canada's largest academic anxiety clinic, a regional referral center for individuals with HD. The study requires a Letter of No Objection from Health Canada and the study will be approved by Hamilton Integrated Research Ethics Board (HiREB).